<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35194974</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2055-5822</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>9</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>ESC heart failure</Title>
          <ISOAbbreviation>ESC Heart Fail</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Myocarditis following mRNA COVID-19 vaccination: call for endomyocardial biopsy.</ArticleTitle>
        <Pagination>
          <StartPage>1996</StartPage>
          <EndPage>2002</EndPage>
          <MedlinePgn>1996-2002</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ehf2.13791</ELocationID>
        <Abstract>
          <AbstractText>Acute myocarditis following mRNA COVID-19 vaccination was reported by the European Medicine Agency safety committee as a rare adverse event. We present a case series of three young male patients with suspected acute myocarditis following BNT162b2 mRNA COVID-19 vaccination including results of endomyocardial biopsies (EMB). Additionally, we analysed EMB of another 21 patients with clinically suspected acute myocarditis following vaccination to determine the pathohistological pattern. Overall, EMB revealed acute lymphocytic myocarditis in 5 (20.8%), chronic lymphocytic myocarditis in 6 (25%), cardiac sarcoidosis in 1 (4.2%), healed myocarditis in 6 (25%), and other diagnoses with cardiac damage of unclear aetiology in 6 (25%) cases. Our findings support the necessity of EMB in patients with suspected acute myocarditis following mRNA COVID-19 vaccination presenting with reduced EF to establish a correct and definite diagnosis. Concerns of these rare severe adverse events after COVID-19 immunization should not undermine its value for the global community.</AbstractText>
          <CopyrightInformation>© 2021 The Authors. ESC Heart Failure published by John Wiley &amp; Sons Ltd on behalf of European Society of Cardiology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kiblboeck</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">0000-0002-0181-516X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Kepler University Hospital, Med Campus III, Medical Faculty, Johannes Kepler University, Linz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Klingel</LastName>
            <ForeName>Karin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiopathology, Institute for Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Genger</LastName>
            <ForeName>Martin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nephrology and Intensive Care, General Hospital Steyr, Steyr, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Traxler</LastName>
            <ForeName>Selina</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiopathology, Institute for Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Braunsteiner</LastName>
            <ForeName>Nathalie</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nephrology and Intensive Care, General Hospital Steyr, Steyr, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Steinwender</LastName>
            <ForeName>Clemens</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Kepler University Hospital, Med Campus III, Medical Faculty, Johannes Kepler University, Linz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kellermair</LastName>
            <ForeName>Joerg</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Kepler University Hospital, Med Campus III, Medical Faculty, Johannes Kepler University, Linz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>ESC Heart Fail</MedlineTA>
        <NlmUniqueID>101669191</NlmUniqueID>
        <ISSNLinking>2055-5822</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>N38TVC63NU</RegistryNumber>
          <NameOfSubstance UI="D000090982">BNT162 Vaccine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000090982" MajorTopicYN="N">BNT162 Vaccine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19</Keyword>
        <Keyword MajorTopicYN="N">Endomyocardial biopsy</Keyword>
        <Keyword MajorTopicYN="N">Myocarditis</Keyword>
        <Keyword MajorTopicYN="N">Vaccination</Keyword>
      </KeywordList>
      <CoiStatement>DK, KK, MG, ST, NB, CS, and JK declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>23</Day>
          <Hour>5</Hour>
          <Minute>38</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35194974</ArticleId>
        <ArticleId IdType="pmc">PMC9065833</ArticleId>
        <ArticleId IdType="doi">10.1002/ehf2.13791</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
European Medicine Agency
Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis. 2021, July 9th. https://www.ema.europa.eu/en/news/comirnaty‐spikevax‐possible‐link‐very‐rare‐cases‐myocarditis‐pericarditis (4 August 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>
Ministry of Health.
Surveillance of myocarditis (inflammation of the heart muscle) cases between December 2020 and May 2021 (including). June 2021. https://gov.il/en/departments/news/01062021‐03 (4 August 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>
Montgomery J, Ryan M, Engler R, Hoffman D, McClenathan B, Collins L, Loran D, Hrncir D, Herring K, Platzer M, Adams N, Sanou A, Cooper LT Jr. Myocarditis following immunization with mRNA COVID‐19 vaccines in members of the US military. JAMA Cardiol
2021; 6: 1202–1206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8243257</ArticleId>
            <ArticleId IdType="pubmed">34185045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rosner CM, Genovese L, Tehrani BN, Atkins M, Bakhshi H, Chaudhri S, Damluji AA, de Lemos JA, Desai SS, Emaminia A, Flanagan MC, Khera A, Maghsoudi A, Mekonnen G, Muthukumar A, Saeed IM, Sherwood MW, Sinha SS, O'Connor CM, deFilippi CR. Myocarditis temporally associated with COVID‐19 vaccination. Circulation
2021; 144: 502–505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8340723</ArticleId>
            <ArticleId IdType="pubmed">34133885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Abu Mouch S, Roguin A, Hellou A, Ishai A, Shoshan U, Mahamid L, Zoabi M, Aisman M, Goldshmidt N, Yanay NB. Myocarditis following COVID‐19 mRNA vaccination. Vaccine
2021; 39: 2790–2793.</Citation>
        </Reference>
        <Reference>
          <Citation>
Mei R, Raschi E, Forcesi E, Diemberger I, de Ponti F, Poluzzi E. Myocarditis and pericarditis after immunization: Gaining insights through the vaccine adverse event reporting system. Int J Cardiol
2018; 273: 183–186.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30236504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno‐Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss H‐P, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J
2013; 34: 2636–2648.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23824828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Das BB, Moskowitz WB, Taylor MB, Palmer A. Myocarditis and pericarditis following mRNA COVID‐19 vaccination: what do we know so far?
Children
2021; 8: 607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8305058</ArticleId>
            <ArticleId IdType="pubmed">34356586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Seferovic PM, Tsutsui H, McNamara DM, Ristić AD, Basso C, Bozkurt B, Cooper LT Jr, Filippatos G, Ide T, Inomata T, Klingel K. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society position statement on endomyocardial biopsy. Eur J Heart Fail
2021; 23: 854–871.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34010472</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35194974</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2055-5822</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>9</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>ESC heart failure</Title>
          <ISOAbbreviation>ESC Heart Fail</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Myocarditis following mRNA COVID-19 vaccination: call for endomyocardial biopsy.</ArticleTitle>
        <Pagination>
          <StartPage>1996</StartPage>
          <EndPage>2002</EndPage>
          <MedlinePgn>1996-2002</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ehf2.13791</ELocationID>
        <Abstract>
          <AbstractText>Acute myocarditis following mRNA COVID-19 vaccination was reported by the European Medicine Agency safety committee as a rare adverse event. We present a case series of three young male patients with suspected acute myocarditis following BNT162b2 mRNA COVID-19 vaccination including results of endomyocardial biopsies (EMB). Additionally, we analysed EMB of another 21 patients with clinically suspected acute myocarditis following vaccination to determine the pathohistological pattern. Overall, EMB revealed acute lymphocytic myocarditis in 5 (20.8%), chronic lymphocytic myocarditis in 6 (25%), cardiac sarcoidosis in 1 (4.2%), healed myocarditis in 6 (25%), and other diagnoses with cardiac damage of unclear aetiology in 6 (25%) cases. Our findings support the necessity of EMB in patients with suspected acute myocarditis following mRNA COVID-19 vaccination presenting with reduced EF to establish a correct and definite diagnosis. Concerns of these rare severe adverse events after COVID-19 immunization should not undermine its value for the global community.</AbstractText>
          <CopyrightInformation>© 2021 The Authors. ESC Heart Failure published by John Wiley &amp; Sons Ltd on behalf of European Society of Cardiology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kiblboeck</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">0000-0002-0181-516X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Kepler University Hospital, Med Campus III, Medical Faculty, Johannes Kepler University, Linz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Klingel</LastName>
            <ForeName>Karin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiopathology, Institute for Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Genger</LastName>
            <ForeName>Martin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nephrology and Intensive Care, General Hospital Steyr, Steyr, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Traxler</LastName>
            <ForeName>Selina</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiopathology, Institute for Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Braunsteiner</LastName>
            <ForeName>Nathalie</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Nephrology and Intensive Care, General Hospital Steyr, Steyr, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Steinwender</LastName>
            <ForeName>Clemens</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Kepler University Hospital, Med Campus III, Medical Faculty, Johannes Kepler University, Linz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kellermair</LastName>
            <ForeName>Joerg</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Kepler University Hospital, Med Campus III, Medical Faculty, Johannes Kepler University, Linz, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>ESC Heart Fail</MedlineTA>
        <NlmUniqueID>101669191</NlmUniqueID>
        <ISSNLinking>2055-5822</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>N38TVC63NU</RegistryNumber>
          <NameOfSubstance UI="D000090982">BNT162 Vaccine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000090982" MajorTopicYN="N">BNT162 Vaccine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19</Keyword>
        <Keyword MajorTopicYN="N">Endomyocardial biopsy</Keyword>
        <Keyword MajorTopicYN="N">Myocarditis</Keyword>
        <Keyword MajorTopicYN="N">Vaccination</Keyword>
      </KeywordList>
      <CoiStatement>DK, KK, MG, ST, NB, CS, and JK declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>23</Day>
          <Hour>5</Hour>
          <Minute>38</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35194974</ArticleId>
        <ArticleId IdType="pmc">PMC9065833</ArticleId>
        <ArticleId IdType="doi">10.1002/ehf2.13791</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
European Medicine Agency
Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis. 2021, July 9th. https://www.ema.europa.eu/en/news/comirnaty‐spikevax‐possible‐link‐very‐rare‐cases‐myocarditis‐pericarditis (4 August 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>
Ministry of Health.
Surveillance of myocarditis (inflammation of the heart muscle) cases between December 2020 and May 2021 (including). June 2021. https://gov.il/en/departments/news/01062021‐03 (4 August 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>
Montgomery J, Ryan M, Engler R, Hoffman D, McClenathan B, Collins L, Loran D, Hrncir D, Herring K, Platzer M, Adams N, Sanou A, Cooper LT Jr. Myocarditis following immunization with mRNA COVID‐19 vaccines in members of the US military. JAMA Cardiol
2021; 6: 1202–1206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8243257</ArticleId>
            <ArticleId IdType="pubmed">34185045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rosner CM, Genovese L, Tehrani BN, Atkins M, Bakhshi H, Chaudhri S, Damluji AA, de Lemos JA, Desai SS, Emaminia A, Flanagan MC, Khera A, Maghsoudi A, Mekonnen G, Muthukumar A, Saeed IM, Sherwood MW, Sinha SS, O'Connor CM, deFilippi CR. Myocarditis temporally associated with COVID‐19 vaccination. Circulation
2021; 144: 502–505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8340723</ArticleId>
            <ArticleId IdType="pubmed">34133885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Abu Mouch S, Roguin A, Hellou A, Ishai A, Shoshan U, Mahamid L, Zoabi M, Aisman M, Goldshmidt N, Yanay NB. Myocarditis following COVID‐19 mRNA vaccination. Vaccine
2021; 39: 2790–2793.</Citation>
        </Reference>
        <Reference>
          <Citation>
Mei R, Raschi E, Forcesi E, Diemberger I, de Ponti F, Poluzzi E. Myocarditis and pericarditis after immunization: Gaining insights through the vaccine adverse event reporting system. Int J Cardiol
2018; 273: 183–186.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30236504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno‐Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss H‐P, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J
2013; 34: 2636–2648.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23824828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Das BB, Moskowitz WB, Taylor MB, Palmer A. Myocarditis and pericarditis following mRNA COVID‐19 vaccination: what do we know so far?
Children
2021; 8: 607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8305058</ArticleId>
            <ArticleId IdType="pubmed">34356586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Seferovic PM, Tsutsui H, McNamara DM, Ristić AD, Basso C, Bozkurt B, Cooper LT Jr, Filippatos G, Ide T, Inomata T, Klingel K. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society position statement on endomyocardial biopsy. Eur J Heart Fail
2021; 23: 854–871.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34010472</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
